Epithelial-mesenchymal transition: A cancer researcher's conceptual friend and foe

American Journal of Pathology

Volumn 174, Issue 5, 2009, Pages 1588-1593

  Klymkowsky, Michael W ^a   Savagner, Pierre ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANOIKIS; CARCINOMA; CELL ADHESION; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL POLARITY; CELL RENEWAL; CELL TRANSFORMATION; CYTOSKELETON; EPITHELIUM CELL; HUMAN; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; DISEASE COURSE; MESODERM; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; MESODERM; NEOPLASMS;

EID: 65649153358     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080545     Document Type: Review

References (68)

1. Bolender D, Markwald R: Epithelial-mesenchymal transformation in chick atrioventricular cushion morphogenesis. Scan Electron Microsc 1979, 3:313-321 (Pubitemid 9239007)
2. Savagner P: Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001, 23:912-923 (Pubitemid 32972691)
3. Baum B, Settleman J, Quinlan M: Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008, 19:294-308
4. Stockinger A, Eger A, Wolf J, Beug H, Foisner R: E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 2001, 154:1185-1196 (Pubitemid 34286196)
5. Valdés F, Alvarez A, Locascio A, Vega S, Herrera B, Fernández M, Benito M, Nieto M, Fabregat I: The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor beta in fetal rat hepatocytes. Mol Cancer Res 2002, 1:68-78 (Pubitemid 36330212)
6. Greenburg G, Hay E: Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchyme-like cells in vitro. Dev Biol 1986, 115:363-379 (Pubitemid 16073364)
7. Greenburg G, Hay ED: Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 1982, 95:333-339 (Pubitemid 13197104)
8. Boyer B, Tucker G, Valles A, Franke W, Thiery J: Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol 1989, 109:1495-1509 (Pubitemid 19251206)
9. Li Y, Joseph A, Bhargava M, Rosen E, Nakamura T, Goldberg I: Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells. In Vitro Cell Dev Biol 1992, 28:364-368
10. Uehara Y, Kitamura N: Expression of a human hepatocyte growth factor/scatter factor cDNA in MDCK epithelial cells influences cell morphology, motility, and anchorage-independent growth. J Cell Biol 1992, 117:889-894
11. Weidner K, Sachs M, Birchmeier W: The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 1993, 121:145-154 (Pubitemid 23097370)
12. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, Schreiber M, Jechlinger M, Beug H: ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 2006, 10:227-239 (Pubitemid 44311068)
13. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142 (Pubitemid 43278296)
14. Berx G, Raspe E, Christofori G, Thiery JP, Sleeman JP: Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis 2007, 24:587-597 (Pubitemid 50000849)
15. Dow LE, Humbert PO: Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis. Int Rev Cytol 2007, 262:253-302 (Pubitemid 47031311)
16. Tarin D, Thompson EW, Newgreen DF: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6001 (Pubitemid 40994379)
17. Barak V, Goike H, Panaretakis KW, Einarsson R: Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004, 37:529-540 (Pubitemid 38845016)
18. Halachmi S, DeMarzo A, Chow N, Halachmi N, Smith A, Linn J, Nativ O, Epstein J, Schoenberg M, Sidransky D: Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin. Eur Urol 2000, 37:350-357 (Pubitemid 30122273)
19. Dacic S, Finkelstein S, Sasatomi E, Swalsky P, Yousem S: Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol 2002, 26:510-516 (Pubitemid 34280126)
20. Fujii H, Yoshida M, Gong Z, Matsumoto T, Hamano Y, Fukunaga M, Hruban R, Gabrielson E, Shirai T: Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 2000, 60:114-120 (Pubitemid 30058740)
21. Thompson L, Chang B, Barsky S: Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 1996, 20:277-285
22. McCarthy R, Zhang S, Bostwick D, Qian J, Eble J, Wang M, Lin H, Cheng L: Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004, 165:1395-1400 (Pubitemid 39297743)
23. Fukino K, Shen L, Matsumoto S, Morrison C, Mutter G, Eng C: Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 2004, 64:7231-7236 (Pubitemid 39372057)
24. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA: Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000, 60:2562-2566 (Pubitemid 30262453)
25. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA, Stone EM, Aaltonen LA: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998, 280:1086-1088
26. Rosai J, Ackerman L: Surgical Pathology, ed 4. New York, Mosby, 2004
27. Kufe DW, Pollock RE, Weichselbaum RR, Bast Jr RC, Gansler TS, Holland JF, Frei III E: Cancer Medicine. Hamilton, BC Decker, 2003
28. Hu L, Lau S, Tzang C, Wen J, Wang W, Xie D, Huang M, Wang Y, Wu M, Huang J, Zeng W, Sham J, Yang M, Guan X: Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 2004, 23:298-302 (Pubitemid 38142264)
29. Ngan C, Yamamoto H, Seshimo I, Tsujino T, Mani M, Ikeda J, Konishi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M: Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer 2007, 96:986-992 (Pubitemid 46452285)
30. Biernat W, Kordek R, Liberski P, Woźniak L: Carcinosarcoma of the skin. Case report and literature review. Am J Dermatopathol 1996, 18:614-619
31. Derksen PWB, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink J, Krimpenfort P, Peterse JL, Cardiff RD, Berns A, Jonkers J: Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449
32. Moll R, Mitze M, Frixen U, Birchmeier W: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993, 143:1731-1742 (Pubitemid 24058276)
33. Côme C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P: Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 2006, 12:5395-5402 (Pubitemid 44497253)
34. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T: Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005, 5:744-749
35. Brakebusch C, Fassler R: Beta 1 integrin function in vivo: adhesion, migration and more. Cancer Metastatsis Rev 2005, 24:403-411 (Pubitemid 41569980)
36. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP: CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 2005, 65:10783-10793 (Pubitemid 41715227)
37. Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J, Turley EA: The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem 2007, 282:16667-16680 (Pubitemid 47100370)
38. Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, Hudson LG: Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 2005, 202:858-866 (Pubitemid 40175863)
39. Storci G, Sansone P, Trere D, Tavolari S, Taffurellii M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, Santini D, Chieco P, Bonafe M: The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008, 214:25-37
40. Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A, Brooks M, Reinhard F, Zhang C, Shipitsin M, Campbel IL, Polyak K, Brisken C, Yang J, Weinberg R: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715
41. Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981
42. Daniel CW, Strickland P, Friedmann Y: Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 1995, 169:511-519
43. Moustakas A, Heldin C-H: Signaling networks guiding epithelial- mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007, 98:1512-1520 (Pubitemid 47308444)
44. Wyatt L, Wadham C, Crocker LA, Lardelli M, Khew-Goodall Y: The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol 2007, 178:1223-1235 (Pubitemid 47480228)
45. Mackenzie NC, Raz E: Found in translation: a new player in EMT. Dev Cell 2006, 11:434-436 (Pubitemid 44430906)
46. Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC: Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 2008, 27:2243-2248
47. Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG, Shim H: CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 2007, 67:7518-7524 (Pubitemid 47206582)
48. Savagner P, Yamada KM, Thiery JP: The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997, 137:1403-1419 (Pubitemid 27265951)
49. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392:190-193 (Pubitemid 28162793)
50. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2:84-89
51. Bolós V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A: The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003, 116:499-511 (Pubitemid 36231290)
52. Yang J, Mani S, Donaher J, Ramaswamy S, Itzykson R, Come C, Savagner P, Gitelman I, Richardson A, Weinberg R: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939 (Pubitemid 38798858)
53. Becker KF, Rosivatz E, Blechschmidt K, Kremmer E, Sarbia M, Hofler H: Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs 2007, 185:204-212 (Pubitemid 46956860)
54. Barrallo-Gimeno A, Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161 (Pubitemid 41167144)
55. Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, Carneiro F, Becker KF: Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 2007, 211:507-515 (Pubitemid 46502426)
56. Kajita M, McClinic KN, Wade PA: Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004, 24:7559-7566 (Pubitemid 39121483)
57. Pérez-Mancera PA, Gonzelez-Herrero I, Perez-Caro M, Gutiirrez-Cianca N, Flores T, Gutierrez-Adan A, Pintado B, Sanchez-Martin M, Sanchez-Garcia I: SLUG in cancer development. Oncogene 2005, 24:3073-3082 (Pubitemid 40695076)
58. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, Look AT: Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005, 123:641-653 (Pubitemid 41613746)
59. Zhang C, Carl TF, Trudeau ED, Simmet T, Klymkowsky MW: An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm. PLoS ONE 2006, 1:e106
60. Arias JI, Aller MA, Arias J: Cancer cell: using inflammation to invade the host. Mol Cancer 2007, 6:29
61. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47 (Pubitemid 37328806)
62. Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T, Konishi I: Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 2003, 163:1437-1447 (Pubitemid 37175091)
63. Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, Kim WY, Saravanan A, Maynard MA, Gervais ML, Sufan RI, Roberts AM, Wilson LA, Betten M, Vandewalle C, Berx G, Marsden PA, Irwin MS, Teh BT, Jewett MA, Ohh M: VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol 2007, 27:157-169 (Pubitemid 46013241)
64. Yang M, Wu K: TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 2008, 7:2090-2096
65. Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A, Portillo F: A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 2005, 24:3446-3458 (Pubitemid 41486782)
66. Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, Trackman PC, Sonenshein GE: The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neudriven breast cancer. Cancer Res 2007, 67:1105-1112 (Pubitemid 46270767)
67. Tlsty TD, Coussens LM: Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006, 1:119-150
68. Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J: Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007, 67:2649-2656 (Pubitemid 46548952)